The SEER database tracks 5-year relative survival rates for myeloma in the United States, based on how far the cancer has spread. The SEER database, however, does not group cancers by the Revised International Staging System (stage 1, stage 2, or stage 3).

Aug 8, 2024 · What is the life expectancy with multiple myeloma? This depends on many factors, including the stage of your cancer at diagnosis and the kind of genetic changes your cancer has.

The overall five-year survival rate for people with multiple myeloma ranges from 40% to 82%. These numbers are based on the Revised Multiple Myeloma International Staging System (R-ISS). It’s important to remember that statistics like these are averages that don’t take factors like age or overall health into consideration.

Oct 24, 2023 · The overall 5-year survival rate for myeloma, based on data from people who received this diagnosis between 2013 and 2019, is 59.8%, according to the National Institutes of Health’s SEER...

May 24, 2024 · The 5-year overall relative survival rate (RSR) for multiple myeloma is 58%, but not as favorable in older adults. Learn more about the prognosis.

Feb 13, 2025 · We have made a great deal of progress in the past two decades, thanks to the development of more effective drugs. The overall five-year survival rate for people with active multiple myeloma in the United States has increased steadily over time, to more than 55% today.

Jun 6, 2022 · According to the National Cancer Institute SEER (Surveillance, Epidemiology and End Rules) Program, the average five-year relative survival rate for multiple myeloma between 2013 and 2019 was about 60 percent. That survival rate changes a bit based on how far the cancer has spread.